CLINICAL_TRIALS
trial_result
· 2013-07-16
Clinical Trial Update: Imatinib (QTI571) in Pulmonary Arterial Hypertension [Phase 3]
Summary
Phase 3 trial of Imatinib for pulmonary arterial hypertension has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-07-16